Alcala C, Quintanilla-Bordas C, Gascon F, Sempere AP, et al. Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study. J Neurol 2022 Feb 2. pii: 10.1007/s00415-022-10989.
PMID: 35107597